Cargando…
Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report
BACKGROUND: Avelumab is an anti-programmed cell death ligand 1 (PD-L1) antibody approved for treatment of Merkel cell carcinoma (MCC) and locally advanced or metastatic urothelial carcinoma. It shares a similar side effect profile to other immune checkpoint inhibitors, including immune-related adver...
Autores principales: | Cardis, Michael A., Jiang, Hong, Strauss, Julius, Gulley, James L., Brownell, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549366/ https://www.ncbi.nlm.nih.gov/pubmed/31164102 http://dx.doi.org/10.1186/s12885-019-5759-1 |
Ejemplares similares
-
The Mitotic Values for the Epithelium in Oral Keratoses and Lichen Planus
por: El-Labban, N., et al.
Publicado: (1971) -
The Use of Discriminant Analysis for Examining the Histological Features of Oral Keratoses and Lichen Planus
por: Kramer, I. R. H., et al.
Publicado: (1970) -
Immunotherapy in Merkel cell carcinoma: role of Avelumab
por: Palla, Amruth R, et al.
Publicado: (2018) -
The use of discriminant analysis for examining the histological features of oral keratoses and lichen planus. Appendix on discriminant analysis.
por: Clarke, M. R.
Publicado: (1970) -
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
por: Bullement, Ash, et al.
Publicado: (2019)